Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sara Pessina, Gabriele Cantini, Dimos Kapetis, Emanuela Cazzato, Natalia Di Ianni, Gaetano Finocchiaro & Serena Pellegatta. (2016) The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma. OncoImmunology 5:5.
Read now
Read now
Articles from other publishers (19)
Nuno Jorge Lamas, Sandra Lassalle, Arnaud Martel, Sacha Nahon-Estève, Adam Macocco, Katia Zahaf, Salome Lalvee, Julien Fayada, Virginie Lespinet-Fabre, Olivier Bordone, Florence Pedeutour, Stéphanie Baillif & Paul Hofman. (2023) Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort. Pathology 55:7, pages 929-944.
Crossref
Crossref
C. Gerard, B. Shum, P. Nathan & S. Turajlic. (2023) Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond. Immuno-Oncology and Technology 19, pages 100386.
Crossref
Crossref
Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio & Carlos R. Figueiredo. (2023) Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities. British Journal of Cancer.
Crossref
Crossref
Jianlan Liu, Pengpeng Zhang, Fang Yang, Keyu Jiang, Shiyi Sun, Zhijia Xia, Gang Yao & Jian Tang. (2023) Integrating single-cell analysis and machine learning to create glycosylation-based gene signature for prognostic prediction of uveal melanoma. Frontiers in Endocrinology 14.
Crossref
Crossref
Seema Kashyap, Mithalesh Kumar Singh, Nikhil Kumar, Jayanti Jha, Neiwete Lomi, Rachna Meel, Sameer Bakhshi, Seema Sen & Lata Singh. (2023) Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients. British Journal of Ophthalmology, pages bjo-2022-322913.
Crossref
Crossref
Lukasz Kuryk & Anne-Sophie W. Møller. (2023) Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models. Molecular Therapy - Oncolytics 28, pages 158-170.
Crossref
Crossref
Feng Zhang, Yan Deng, Dong Wang & Shuai Wang. (2023) Construction and Verification of the Molecular Subtype and a Novel Prognostic Signature Based on Inflammatory Response-Related Genes in Uveal Melanoma. Journal of Clinical Medicine 12:3, pages 861.
Crossref
Crossref
Carla Enrica Gallenga, Elena Franco, Ginevra Giovanna Adamo, Sara Silvia Violanti, Paolo Tassinari, Mauro Tognon & Paolo Perri. (2022) Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis. Frontiers in Oncology 12.
Crossref
Crossref
Xiaohui Lv, Min Ding & Yan Liu. (2022) Landscape of Infiltrated Immune Cell Characterization in Uveal Melanoma to Improve Immune Checkpoint Blockade Therapy. Frontiers in Immunology 13.
Crossref
Crossref
Zhishang Meng, Yanzhu Chen, Wenyi Wu, Bin Yan, Lusi Zhang, Huihui Chen, Yongan Meng, Youling Liang, Xiaoxi Yao & Jing Luo. (2022) PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial–Mesenchymal Transition in Uveal Melanoma. Frontiers in Immunology 13.
Crossref
Crossref
Anna Tosi, Rocco Cappellesso, Angelo Paolo Dei Tos, Valentina Rossi, Camillo Aliberti, Jacopo Pigozzo, Alessio Fabozzi, Marta Sbaraglia, Stella Blandamura, Paola Del Bianco, Vanna Chiarion-Sileni & Antonio Rosato. (2021) The immune cell landscape of metastatic uveal melanoma correlates with overall survival. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Mieszko Lachota, Anton Lennikov, Karl-Johan Malmberg & Radoslaw Zagozdzon. (2021) Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression. Journal of Immunology Research 2021, pages 1-18.
Crossref
Crossref
Charlotte Pandiani, Thomas Strub, Nicolas Nottet, Yann Cheli, Giovanni Gambi, Karine Bille, Chrystel Husser, Mélanie Dalmasso, Guillaume Béranger, Sandra Lassalle, Virginie Magnone, Florence Pédeutour, Marie Irondelle, Célia Maschi, Sacha Nahon-Estève, Arnaud Martel, Jean-Pierre Caujolle, Paul Hofman, Kévin LeBrigand, Irwin Davidson, Stéphanie Baillif, Pascal Barbry, Robert Ballotti & Corine Bertolotto. (2021) Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease. Cell Death & Differentiation 28:6, pages 1990-2000.
Crossref
Crossref
Zenan Lin & Daniela Süsskind. (2021) Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases. Journal of Cancer Research and Clinical Oncology 147:5, pages 1389-1405.
Crossref
Crossref
Igor Tsaur, Maximilian P. Brandt, Eva Juengel, Cécile Manceau & Guillaume Ploussard. (2020) Immunotherapy in prostate cancer: new horizon of hurdles and hopes. World Journal of Urology 39:5, pages 1387-1403.
Crossref
Crossref
Andrea Soltysova, Tatiana Sedlackova, Dana Dvorska, Karin Jasek, Pooneh Chokhachi Baradaran, Viera Horvathova Kajabova, Lucia Demkova, Verona Buocikova, Terezia Kurucova, Darina Lyskova, Alena Furdova, Gabriel Minarik, Pavel Babal, Zuzana Dankova & Bozena Smolkova. (2020) Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy. International Journal of Molecular Sciences 21:24, pages 9651.
Crossref
Crossref
Marianne Strazza & Adam Mor. (2020) The Complexity of Targeting Chemokines to Promote a Tumor Immune Response. Inflammation 43:4, pages 1201-1208.
Crossref
Crossref
Hong-Tai Tzeng, I-Tsu Chyuan & Wei-Yu Chen. (2019) Shaping of Innate Immune Response by Fatty Acid Metabolite Palmitate. Cells 8:12, pages 1633.
Crossref
Crossref
Florian Castet, Sandra Garcia-Mulero, Rebeca Sanz-Pamplona, Andres Cuellar, Oriol Casanovas, Josep Caminal & Josep Piulats. (2019) Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?. Cancers 11:6, pages 834.
Crossref
Crossref